Connect your AI

Collegium Pharmaceutical, Inc. COLL Net margin

Net margin at other companies

Indivior Pharmaceuticals, Inc. INDV

19.4%+18.9pp

Catalyst PharmaceuticalCPRX

37.1%+0.2pp

Avanos MedicalAVNS

-10.4%-4.7pp

Pacira BioSciences, Inc.PCRX

0.7%—

Supernus PharmaceuticalsSUPN

-3.7%-13.0pp

Theravance BiopharmaTBPH

104.3%+71.4pp

Other financials

Income statement

Revenue$193.5M+8.9%

Gross profit$117.2M+20.5%

Operating income$30.9M+42.5%

Net income$14.5M+500%

EPS (diluted)$0.40+471%

Balance sheet

Cash & equivalents$289.6M+147%

Total debt$5.2M-19.5%

Total equity$312.4M+33.3%

Total assets$1.7B+1.3%

Cash flow

Operating cash flow$57.1M+3.1%

CapEx$270.0K-66.2%

Free cash flow$56.8M+4.1%

Valuation

Market cap$1.15B+20.4%

Enterprise value$869.67M+2.5%

P/E15.4×-6.4×

P/S1.5×0.0×

Profitability

Gross margin60.7%+3.0pp

Operating margin23.7%+2.3pp

FCF margin41.4%+10.4pp

Returns & leverage

Return on equity27.4%+8.2pp

Debt / equity0×0.0×

Current ratio1.7×+0.6×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

net income/total revenue=9.4%

Based on trailing twelve months.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s net margin?: Collegium Pharmaceutical, Inc. (COLL) reported net margin of 9.4% in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s net margin changed year-over-year?: Collegium Pharmaceutical, Inc.'s net margin increased by 42.4% year-over-year, from 6.6% to 9.4%.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s net margin?: Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s net margin has grown at a -1.4% compound annual growth rate (CAGR), from 8.6% to 8.1%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.